Replies to post #97 on NeuroSense Therapeutics Ltd (NRSN)

[stockforce]

At 13 minutes in the webinar, the CEO said: the results obtained from our phase 2b study will dictate our regulatory strategy as there is a chance we could file directly based on these results"! WOW! if the results can be this good, $NRSN will run past $10 overnight! This is huge. Great confidence from the CEO.